EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial

Xavier Serra-Aracil iD, Alba Zarate, Josep Bargalló, Anna Gonzalez, Anna Serracant, Jordi Roura, Salvadora Delgado, Laura Mora-López, Ta-LaTME study Group

British Journal of Surgery · 10.01.2023 · 110 (2) · 150-158

DOI: 10.1093/bjs/znac324 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 13.10.2022. Verfasst von Xavier Serra-Aracil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Despartment of Surgery, Coloproctology Unit, Parc Tauli University Hospital, Sabadell, Institut d'investigació i innovació Parc Tauli I3PT, Universit…. Hauptthemen laut MEDLINE: Transanal Endoscopic Surgery, Rectal Neoplasms, Laparoscopy. Die Arbeit wurde bisher 67-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transanal total mesorectal excision (TaTME) is a minimally invasive surgical technique that tries to avoid conversion to open surgery. However, specific intraoperative complications and local recurrences have cast some doubt on the suitability of the technique. The primary endpoint of the present study was a composite outcome of conversion surgery. Secondary objectives were to assess postoperative recovery, and pathological and oncological outcomes.

Methods

This was a prospective, multicentre, randomized, controlled open-label study of patients diagnosed with mid and low rectal adenocarcinoma who underwent laparoscopic TaTME or laparoscopic total mesorectal excision (LaTME). The TaTME technique comprised intracorporeal resection and anastomosis. Main outcomes were conversion to open surgery. Secondary outcomes were postoperative morbidity, mortality, pathological, oncological results, and survival. Modified intention-to-treat (mITT) and per-protocol analyses were performed.

Results

The study was conducted between April 2015 and May 2021. Patients were randomized to the LaTME (57 patients) or TaTME (59) group. Fifty patients from the LaTME group and 55 from the TaTME group were eligible for mITT analysis. The procedure was converted to open surgery in 11 patients (11 per cent): 10 (20 per cent) in the LaTME group and 1 (2 per cent) in the laparoscopic TaTME group (difference 18.8, 95 per cent c.i. 30 to 7; P = 0.003). No significant differences were found in terms of postoperative recovery and morbidity at 30 days; nor were there significant differences in anastomotic leakage, although it was less common in laparoscopic TaTME. With a median follow-up of 39 months, there were three instances of local recurrence (6.1 per cent) in the LaTME group and one (1.8 per cent) in the laparoscopic TaTME group (95 per cent c.i. 60 to 69; P = 0.3). Registration number: NCT02550769 (http://www.clinicaltrials.gov).

Conclusion

The conversion rate was significantly lower in laparoscopic TaTME than in LaTME. At centres with experienced surgeons, laparoscopic TaTME can avoid conversion to open surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transanal Endoscopic SurgeryRectal NeoplasmsLaparoscopyHumansProspective StudiesPostoperative ComplicationsRectumTreatment Outcome

Autor:innen und Institutionen

  • Despartment of Surgery, Coloproctology Unit, Parc Tauli University Hospital, Sabadell, Institut d'investigació i innovació Parc Tauli I3PT, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • General and Digestive Surgery Department, Hospital Consorcio Sanitario Terrassa, Terrassa, Spain.
  • General and Digestive Surgery Department, Hospital General de Catalunya, Barcelona, Spain.
  • Coloproctology Unit, General and Digestive Surgery Department, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.

ORCID-Profile: Xavier Serra-Aracil

Zitieren

APA

Serra-Aracil, X., Zarate, A., Bargalló, J., Gonzalez, A., Serracant, A., Roura, J., Delgado, S., Mora-López, L., & Ta-LaTME study Group (2023). Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial. British Journal of Surgery, 110(2), 150-158. https://doi.org/10.1093/bjs/znac324

Vancouver

Serra-Aracil X, Zarate A, Bargalló J, Gonzalez A, Serracant A, Roura J, et al. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial. British Journal of Surgery. 2023;110(2):150-158. doi:10.1093/bjs/znac324

BibTeX
@article{SerraAracil2023,
  author = {Serra-Aracil, Xavier and Zarate, Alba and Bargalló, Josep and Gonzalez, Anna and Serracant, Anna and Roura, Jordi and Delgado, Salvadora and Mora-López, Laura and Ta-LaTME study Group, Ta-LaTME study Group},
  title = {Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial},
  journal = {British Journal of Surgery},
  year = {2023},
  volume = {110},
  number = {2},
  pages = {150--158},
  doi = {10.1093/bjs/znac324}
}
Kostenlos starten →